State v. Keller

2024 N.H. 42, 324 A.3d 973
CourtSupreme Court of New Hampshire
DecidedAugust 14, 2024
Docket2023-0138
StatusPublished

This text of 2024 N.H. 42 (State v. Keller) is published on Counsel Stack Legal Research, covering Supreme Court of New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Keller, 2024 N.H. 42, 324 A.3d 973 (N.H. 2024).

Opinion

NOTICE: This opinion is subject to motions for rehearing under Rule 22 as well as formal revision before publication in the New Hampshire Reports. Readers are requested to notify the Reporter, Supreme Court of New Hampshire, One Charles Doe Drive, Concord, New Hampshire 03301, of any editorial errors in order that corrections may be made before the opinion goes to press. Errors may be reported by email at the following address: reporter@courts.state.nh.us. Opinions are available on the Internet by 9:00 a.m. on the morning of their release. The direct address of the court’s home page is: https://www.courts.nh.gov/our-courts/supreme-court

THE SUPREME COURT OF NEW HAMPSHIRE

___________________________

Belknap Case No. 2023-0138 Citation: State v. Keller, 2024 N.H. 42

THE STATE OF NEW HAMPSHIRE

v.

OTTO KELLER

Argued: June 13, 2024 Opinion Issued: August 14, 2024

John M. Formella, attorney general, and Anthony J. Galdieri, solicitor general (Sam M. Gonyea, assistant attorney general, on the brief and orally), for the State.

Pamela E. Phelan, senior assistant appellate defender, of Concord, on the brief, and Kirkland & Ellis LLP, of Chicago, Illinois (Helen E. Witt on the brief and orally), for the defendant.

DONOVAN, J.

[¶1] The defendant, Otto Keller, appeals a decision from Superior Court (O’Neill, J.) denying his motion in limine and allowing the testimony of Colleen Scarneo, the State’s expert on “human performance forensic toxicology,” and a decision from Superior Court (Attorri, J.) denying his motion to dismiss his conviction on one count of aggravated driving while intoxicated (ADWI) for causing a collision resulting in serious bodily injury. See RSA 265-A:3, I(b) (2024). The defendant argues that: (1) the methodology that Scarneo used was not sufficiently reliable to meet the requirements for admission; and (2) the evidence was insufficient to prove the required element of serious bodily injury. We conclude that the trial court erred in admitting Scarneo’s testimony because the methodology that she used was not sufficiently reliable to meet the requirements for admission, and that such testimony prejudiced the outcome of the case. We also conclude that the evidence was insufficient to prove serious bodily injury. Accordingly, we reverse the defendant’s ADWI conviction and remand for proceedings consistent with this opinion.

I. Facts

[¶2] The jury could have found the following facts. Shortly after 1:00 a.m. on September 1, 2018, the defendant fell asleep while driving, drove his car over the center line into the oncoming lane of traffic, and crashed into an unoccupied car and the side of a house on the opposite side of the road about 1,000 feet from his house. After the crash, the defendant returned to his residence, and his girlfriend took him to the hospital. His girlfriend called the police and reported the crash.

[¶3] Officer McCormack spoke with the defendant at the hospital approximately forty minutes after the crash while another officer, Officer Goodheart, investigated the crash scene. McCormack did not observe any signs of impairment, such as bloodshot or watery eyes, slurred speech, or an odor of alcohol. The defendant told McCormack that he had used heroin that evening, approximately five hours before the crash, and that he was involved in a methadone clinic. The officer recalled that the defendant also told him “that he had been involved in a car crash and had some serious injuries regarding that.” The defendant consented to a blood draw, which revealed acetyl fentanyl, norfentanyl, fentanyl, methadone, methamphetamine, and amphetamine in his system.

[¶4] Several days after the crash, Officer Goodheart contacted the defendant and asked him to speak to her about the incident. The defendant agreed, and the officer subsequently met with him at the defendant’s residence. When the officer arrived at the defendant’s home, she noticed that his arm was in a sling. The defendant told the officer that, as a result of the crash, he had sustained “a few small lacerations to the top of his head, but his only significant injury was the broken right humerus.” Although the defendant admitted that he had used heroin, fentanyl, or a combination thereof at least four hours prior to the accident, and that he fell asleep or passed out while

2 behind the wheel when he left his home at approximately 1:00 a.m., he maintained that his substance misuse did not contribute to the crash.

[¶5] The defendant was charged with ADWI in violation of RSA 265-A:3, I(b). The State identified Scarneo as an expert witness in human performance forensic toxicology. According to her expert witness disclosure, Scarneo anticipated testifying about the “the pharmacological and toxicological effects associated with the drugs found in [the defendant’s] blood when used alone and concomitantly, as well as their effects on driving.” Scarneo also anticipated opining that the defendant “demonstrated signs and symptoms of impairment that are consistent with the acute effects of acetyl fentanyl and fentanyl combined with the withdrawal effects from methamphetamine and cocaine use” and that “this combination of effects would impair a person’s ability to stay alert or awake, concentrate on the road and maintain control of their vehicle while driving.”

[¶6] The defendant moved in limine to preclude Scarneo’s testimony, arguing that her “proposed testimony is not the product of reliable methods.” The defendant argued, inter alia, that Scarneo’s methodology was unreliable because it did not satisfy the four factors set forth in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592-94 (1993), and codified in RSA 516:29-a, II (2021), and, therefore, her testimony was inadmissible under New Hampshire Rule of Evidence 702. See State v. Langill, 157 N.H. 77, 85 (2008). The State objected.

[¶7] The court held a two-day hearing in September and December 2021 on the defendant’s motion. Scarneo testified that she had been running her own forensic toxicology consulting business for about one year, prior to which she worked in the state forensic toxicology laboratory as a forensic toxicologist. Scarneo testified that while working at the state laboratory, she performed blood tests, interpreted the results of blood tests indicating the presence of drugs in a person’s system, and opined as to whether the person exhibited signs and symptoms of impairment consistent with the drugs found in the person’s blood. To formulate an opinion, Scarneo testified that she reviews a variety of information, including the blood test results, information about the blood collection, discovery materials related to the individual and the incident, information about the drugs found in the person’s body, and any relevant literature, while drawing upon her own education, training, and experience. Scarneo’s work culminates in a report that details her findings and ultimate opinion. Scarneo also testified as to whether the methodology that she uses to formulate her opinion can be tested, has been peer reviewed, has a potential error rate, and is widely accepted. See RSA 516:29-a, II(a) (setting forth factors courts shall consider when determining the admissibility of an expert’s opinion).

3 [¶8] Regarding the defendant’s case, Scarneo testified that she reviewed three different police reports, including reports written by McCormack and Goodheart, a witness statement from the defendant’s girlfriend, the defendant’s medical records, and the results from the blood sample taken from the defendant on the night of the crash.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Baxter Ex Rel. Baxter v. Temple
949 A.2d 167 (Supreme Court of New Hampshire, 2008)
State v. Langill
945 A.2d 1 (Supreme Court of New Hampshire, 2008)
State v. Christopher Gay
145 A.3d 1066 (Supreme Court of New Hampshire, 2016)
State v. Cressey
628 A.2d 696 (Supreme Court of New Hampshire, 1993)
Baker Valley Lumber, Inc. v. Ingersoll-Rand Co.
813 A.2d 409 (Supreme Court of New Hampshire, 2002)
State v. Dahood
814 A.2d 159 (Supreme Court of New Hampshire, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
2024 N.H. 42, 324 A.3d 973, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-keller-nh-2024.